Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
12/2005
12/29/2005CA2612146A1 Treating cancer
12/29/2005CA2571293A1 2-benzylaminodihydropteridinones, method for producing them and use thereof as drugs
12/29/2005CA2570392A1 Peptide vaccine for cancer therapy
12/29/2005CA2569697A1 A pharmaceutical composition and its use
12/29/2005CA2569687A1 Methods of modulating cellular activity involving sphingosine kinase and agents for same, and sphingosine kinase variants
12/29/2005CA2568756A1 Substituted quinazolones as anti-cancer agents
12/29/2005CA2568601A1 Peptide-based compounds
12/28/2005EP1609863A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/28/2005EP1609858A1 Branched neutral amino acid transporters acting as single molecule
12/28/2005EP1609803A1 Modified antibody against cd22 and utilization thereof
12/28/2005EP1609802A1 Transcriptional factor inducing apoptosis in cancer cell
12/28/2005EP1609797A1 Compound having affinity with calcified tissue
12/28/2005EP1609781A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine
12/28/2005EP1609479A1 Tumorigenesis inhibitor
12/28/2005EP1609476A1 Composition for treating hepatitis c
12/28/2005EP1609474A1 Method for preparing therapeutic agent for cancer
12/28/2005EP1608754A2 Modulation of cell phenotype by inhibitory rna
12/28/2005EP1608684A2 Amphiregulin antibodies and their use to treat cancer and psoriasis
12/28/2005EP1608664A1 Non-cross-linking pyrrolo (2,1-c] (1,4]benzodiazepines as potential antitumour agents and process thereof
12/28/2005EP1608663A1 Pyrrolo (2,1-c)(1,4) benzodiazepines dimers as antitumour agents and process thereof
12/28/2005EP1608656A2 Imidazotriazine compounds
12/28/2005EP1608652A1 Pyrazolopyrimidine compounds and their use in medicine
12/28/2005EP1608650A1 Pyrene-linked pyrrolo(2,1-c)(1,4)benzodiazepine derivatives useful as anticancer agents
12/28/2005EP1608639A2 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders
12/28/2005EP1608626A1 Migrastatin analog compositions and uses thereof
12/28/2005EP1608623A1 Metal ion chelators and therapeutic use thereof
12/28/2005EP1608400A1 Elevation of adenosine level by cytokine-induced expression of cd73
12/28/2005EP1608397A1 S100 protein as neutrophil activator for alleviating neutropenia in cancer treatment
12/28/2005EP1608395A1 Anticancer agent comprising lk8 protein as an active ingredient
12/28/2005EP1608389A1 Active ingredient combinations of plant oils containing omega-3 fatty acids and plant extracts containing isoprenoids and the use thereof
12/28/2005EP1608384A2 Therapy for primary and metastatic cancers
12/28/2005EP1608381A2 Novel therapeutic application for a composition
12/28/2005EP1608359A2 Tumor-targeting drug-loaded particles
12/28/2005EP1608353A1 Prevention and treatment of breast cancer with 4-hydroxy tamoxifen
12/28/2005EP1608306A2 Alkyl-substituted pcdf as a treatment for prostate cancer
12/28/2005EP1527076B1 Dihydro-dibenzo[b,e]oxepine based selective estrogen receptor modulators, compositions and methods
12/28/2005EP1470124B1 2-(PYRIDIN-2-YLAMINO)-PYRIDO 2,3-d]PYRIMIDIN-7-ONES
12/28/2005EP1432450B1 Therapeutically useful triethyleneglycol cholesteryl oligonucleotides
12/28/2005EP1427403B1 Valproic acid for the treatment of breast cancer, colon cancer, head and neck cancer, small cell lung carcinoma and cancer of the blood cells in combination with irradiation
12/28/2005EP1414438B1 Antineoplastic combinations
12/28/2005EP1385512B1 Use of pyridoindolone derivatives for preparing anticancer medicines
12/28/2005EP1382604B1 Quinoline derivative having azolyl group and quinazoline derivative
12/28/2005EP1330258B1 Kahalalide f formulation
12/28/2005EP1303641B1 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching
12/28/2005EP1254131B8 Extraction of flavonoids
12/28/2005EP1246627B1 Polyanhydrides with biologically active degradation products
12/28/2005EP1173433B1 Cyanopyrroles as progesterone receptor agonists
12/28/2005EP1124810B9 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/28/2005EP1049686B9 Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
12/28/2005EP1011717B1 Arginine deiminase derived from mycoplasma arthritidis and polymer conjugates containing the same
12/28/2005EP0991658B1 Dolastatin 15 derivatives
12/28/2005EP0971959B1 Humanized antibodies and methods for forming humanized antibodies
12/28/2005EP0918514B1 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma
12/28/2005EP0879281B1 Methods for transforming dendritic cells and activating t cells
12/28/2005EP0876387B1 Use of roxithromycin for the preparation of a medicament for improving the biological and antiviral activity of protease inhibitors
12/28/2005EP0797676B1 Recombinant adenoviral vector and methods of use
12/28/2005EP0646175B1 Recombinant pseudomonas exotoxin with increased activity
12/28/2005CN1714096A Mmp inhibitors
12/28/2005CN1714093A Diazinopyrimidines
12/28/2005CN1714092A Thieno[3,2-b]pyridine-6-carbonitriles and thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
12/28/2005CN1714091A Meso-substituted porphyrins
12/28/2005CN1714090A Quinolinyl-pyrrolopyrazoles
12/28/2005CN1714084A Pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/28/2005CN1713922A Combinations of (a) an ATP-competitive inhibitor of c-acl kinase activity with (b) two or more other antineoplastic agents
12/28/2005CN1713894A Method for preparing a compound of interaction of active substances with a porous support using supercritical fluid
12/28/2005CN1233831C SiRNA and expression plasmid for inhibiting human bc1-2 gene expression and their use for preparing medicine
12/28/2005CN1233823C Antigen-sensitive human GM-CSF gene modified human dendritic cell and its preparing process and usage
12/28/2005CN1233658C Anti endothelial cell element, genes encoding same and pharmaceutical uses thereof
12/28/2005CN1233642C Novel anticancer plants extract and process of extraction thereof
12/28/2005CN1233621C Substituted biphenyl derivatives, method for preparing same and pharmaceutical compositions containing same
12/28/2005CN1233612C Hydroxyanthraquinone derivatives and their application in preparation of anticancer medicines
12/28/2005CN1233415C CD26/DPP IV application in preparation of medicine for treating and/or diagnosing disease
12/28/2005CN1233411C Natural medicine of eliminating tumour internally
12/28/2005CN1233389C Chinese medicinal preparation made from ginseng and astragalus root for strengthening the body resistance and resisting cancer as well as producing method
12/28/2005CN1233370C Medicine for treating ovary cyst and its preparing process
12/28/2005CN1233354C Chinese medicine preparation for treating carcinoma of esophagus
12/28/2005CN1233353C Traditional Chinese medicine for treating cancer
12/28/2005CN1233349C Heat-clearing, toxin-expelling, swell-subsiding Chinese medicinal composition and its use
12/28/2005CA2569200A1 Humanized anti-tag-72 monoclonal antibodies
12/27/2005US6979747 Antioxidants, preparation processes and their uses
12/27/2005US6979730 Nucleic acids encoding prostate stem cell antigen
12/27/2005US6979726 Immunoconjugates
12/27/2005US6979694 Drugs such as (5-(((2,4,6-Trimethylphenyl)amino)carbonyl)-4-methyl-2-thiazolyl)carbamic acid, 1,1-dimethylethyl ester, used as enzyme inhibitors, for prohylaxis of inflammatory bowel disease; modulation of immunology
12/27/2005US6979691 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
12/27/2005US6979684 useful as antitumor or anticancer agents
12/27/2005US6979683 Polymerase enzyme inhibitors
12/27/2005US6979681 Half-sandwich ruthenium (II) compounds comprising nitrogen containing ligands for treatment of cancer
12/27/2005US6979676 Pharmaceutical composition containing and indolopyrrolocarbazole derivative
12/27/2005US6979554 polypeptide has an affinity for a phospholipid selected from a phosphatidylserine, a phosphatidylethanolamine, a phosphatidylinositol, a phosphatidic acid, and a cardiolipin
12/27/2005US6979539 Regulation of endogenous gene expression in cells using zinc finger proteins
12/27/2005US6979466 Iron oxide core with overcoating shell; antitumor agents
12/27/2005CA2428271C Cyanopyrrolidine derivatives as inhibitors of dpp-iv
12/27/2005CA2290506C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors
12/22/2005WO2005121343A1 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof
12/22/2005WO2005121341A1 Tumor specific antibody
12/22/2005WO2005121340A1 Novel galectin 8 modification protein and use thereof
12/22/2005WO2005121338A1 Anti-perp antibody
12/22/2005WO2005121180A1 Humanized anti-tag-72 monoclonal antibodies
12/22/2005WO2005121176A1 Angiogenesis-inhibiting chimeric protein and the use
12/22/2005WO2005121172A2 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
1 ... 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 ... 2211